|View printer-friendly version|
|May 31, 2001 11:30 a.m.|
|Teva Announces Final Approval of Famotidine Tablets,10mg|
180-Day Market Exclusivity
Jerusalem, Israel, May 31, 2001 - Teva Pharmaceutical Industries Ltd.(Nasdaq:TEVA)announced today that the U.S. Food and Drug Administration (FDA)has awarded final approval for Famotidine TabletsUSP,10 mg. This OTC product will be marketed through an alliance with Perrigo Company. Launch is anticipated immediately.